期刊文献+

VEGF干扰慢病毒载体的构建及其在MHCC97L细胞中的表达 被引量:2

Construction of VEGF gene lentiviral RNA interference vector and its expression in MHCC97L cells
下载PDF
导出
摘要 目的构建VEGF基因RNA干扰(RNAi)慢病毒载体并实现其在人肝癌细胞MHCC97L中表达。方法根据人VEGF基因序列,设计并合成包含靶序列的互补DNA链,连接线性化的plenti6.3-MIR载体,构建miRNA慢病毒载体质粒,并转化至感受态细胞DH5α,进行测序验证。在脂质体介导下转染293T细胞,包装生产慢病毒,测定其滴度。慢病毒载体转染人肝癌细胞MHCC97L,用Real-time PCR检测RNAi组(MHCC97-200)、阴性对照组(MHCC97-NEGA)和空白对照组(MHCC97-空白)中VEGF的表达情况,确定其干扰VEGF表达的有效性。结果测序证实慢VEGF基因RNAi病毒载体质粒构建成功。慢病毒载体经293T细胞包装成功,测定病毒的滴度为3.23×109TU/mL。慢病毒载体转染人肝癌细胞MHCC97L 48 h后,VEGF基因在mRNA水平抑制了72.2%。结论 VEGF基因RNAi慢病毒载体构建成功,并实现在人肝癌细胞MHCC97L中的表达。 Objective To construct the lentiviral RNA interference(RNAi) vector of human VEGF gene and realize the expression in human liver cancer cells MHCC97L.Methods According to the sequence of human VEGF gene,the complementary DNA chains which contain the target sequence were designed and synthesized,and then were connected to linear plenti6.3-MIR carriers in order to construct the miRNA lentiviral vector plasmid.The plasmid was transformed to DH5α cells,and the sequence were verified;293T cells were infected by the lentiviral vector plasmid with liposome mediated,lentiviral vectors were packaged,and the titer was measured.The human liver cancer cells MHCC97L were infected by the lentiviral vectors,and the VEGF expression in RNAi group(MHCC97-200),the negative control group(MHCC97-NEGA) and the blank control group(MHCC97-blank) were detected by Real-time PCR,to ensure the jamming effect of lentiviral vector plasmid to VEGF expression.Results The VEGF RNAi lentiviral vector plasmid was constructed successfully.The lentiviral vector was packed successfully,and the virus titer was 3.23×109 TU/mL.The VEGF gene expression was reduced by 72.2% at mRNA level 48 h after the human liver cancer cells MHCC97L were infected by the lentiviral vectors.Conclusion The lentiviral RNAi vector of human VEGF gene is constructed successfully,and expressed effectively in MHCC97L cells.
出处 《中国医药导报》 CAS 2012年第35期11-13,共3页 China Medical Herald
基金 国家自然科学基金(项目编号:81001524) 北京中医药大学自主选题项目(项目编号:2011JYBZZJS-020)
关键词 VEGF基因 慢病毒载体 RNA干扰 MHCC97L细胞 VEGF gene Lentiviral vector RNA interference MHCC97L cells
  • 相关文献

参考文献10

  • 1Suzuki H,Seto K,Shinoda Y, et al. Paracrine upregulation of VEGF re- ceptor mRNA in endothelial cells by hypoxia-exposed HepG2 cells [J]. Am J Physiol, 1999,276( 1 Pt i ) :92-97.
  • 2Zhou S,Tan C,Dai Z,et al. Tacrolimus Enhances the invasion potential of hepatocellular carcinoma cells and promotes lymphatic metastasis in a rat model of hepatocellular carcinoma :involvement of vascular endothe- lial growth ~actor-C [J]. Transplantation Proceedings,2011,43 (7): 2747-2754.
  • 3Inoue K,Torimura T,Nakamura T,et al. Vandetanib,an inhibitor of VEGF receptor-2 and EGF receptor,suppresses tumor development and im- proves prognosis of liver cancer in mice [J]. Clin Cancer Res,2012,18(14) : 3924-3933.
  • 4Hammond SM,Bernstein E,Beach D,et al. An RNA-directed nuelease mediates post-transcriptional gene silencing in Drosophila cells [J]. Na- ture, 2000,404 (6775) : 293-296.
  • 5Brummelkamp TR,Bernards R,Agami R. A system for stable expression of short interfering RNAs in mammalian cells [J]. Science,2002,296 (5567) :550-553.
  • 6Pushparaj PN,Aarthi JJ,Manikandan J,et al. siRNA,miRNA,and shRNA : in vivo applications [J]. J Dent Res, 2008,87 ( 11 ) : 992-1003.
  • 7Heilbronn R,Weger S. Viral vectors for gene transfer:current status of gene therapeutics [J]. Handb Exp Pharmaco1,2010, (197) : 143-170:.
  • 8Leite LH,Sharma NM,Bafna S,et al. Construction and validation of lentiviral vector carrying rat neuronal nitric oxide synthase in vitro and in vivo [J]. J Neurosci Methods ,2012,211 ( 1 ) :77-83.
  • 9Liu X,Tang Z,Zhang Y,et al. Lentivirally overexpressed T-bet regulates T-helper cell lineage commitment in chronic hepatitis B patients [J]. Mol Med Report,2012,6(2) :361-366.
  • 10Chang SH,Chung YS,Hwang SK. Lentiviral vector-mediated shRNA a- gainst AIMP2-DX2 suppresses lung cancer cell growth through block- ing glucose uptake [J]. Mol Cells,2012,33(6):553-562.

同被引文献29

  • 1利显民,江美芳.鼻咽癌VEGF的表达和微血管密度与肿瘤化疗敏感性的关系研究[J].现代肿瘤医学,2008,16(11):1884-1886. 被引量:1
  • 2曾益新.鼻咽癌分子遗传学研究成果简介[J].中国科学基金,2006,20(4):233-235. 被引量:3
  • 3王维群,姜文凯.低氧运动与骨骼肌血管内皮细胞生长因子[J].武汉体育学院学报,2007,41(2):52-57. 被引量:3
  • 4刘育希 曾毅 等.应用免疫酶法测定鼻咽癌病人的免疫球蛋白A抗体[J].中华肿瘤杂志,1979,1(1):8-8.
  • 5Krishna S M, James S, Balaram P.Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status[J].Virus research, 2006, 115 ( 1 ) : 85-90.
  • 6Baujat B, Audry H, Bourhis J, et al.Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients [J].Int J Radiation Oncology Biol Phys, 2006, 64 ( 1 ) : 47-56.
  • 7Fischer PM. Cap in hand: targeting elF4E[J]. Cell Cycle, 2009,8(16) : 2535-2541.
  • 8Wu M, Liu Y, Di X, et al. eIF4E over-expresses and en- hances cell proliferation and cell cycle progression in na- sopharyngeal earcinoma[J]. Med Oncol, 2013,30 ( 1 ) : 400- 409.
  • 9Zheng J, Li J, Xu L, et al. Phosphorylated Mnkl and eIF4E are associated with lymph node metastasis and poor prognosis of nasopharyngeal carcinoma [J/OL]. PLoS One, 2014- 02- 14 [2014-10-25], http://www, ncbi. nlm. nih. gov/pubmed/24551240.
  • 10Moussavi M, Moshgabadi N, Fazli L, et al. Fibroblast growth factor and ornithine decarboxylase 5rUTRs enable preferential expression in human prostate cancer cells and in prostatetumors of PTEN(-/-) transgenic mice[J]. Cancer Gene T- her,2012,19(1) :19-29.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部